I.B.N. Savio owns a broad portfolio of pharmaceutical and, more broadly, healthcare products, which it promotes directly through its Savio Pharma Italia division or licenses to third-party companies for commercialization in both domestic and international markets. The company also oversees the full distribution of its products across the country, relying on highly qualified and specialized partners to ensure efficient and professional deliveries.
Musculoskeletal
-
LENOTAC - Piroxicam - OTC
- Diabetological
-

LIPONAX SOL
LIPONAX SOL - R(+) alpha-lipoic acid - Supplement
Cardiovascular
-
LIPSIN - Fenofibrate - Class A - RR - Note 13
Gastroenterology
-
LITOFF - Ursodeoxycholic acid - Class A - RR - Note 2
Anti-infective
-
MEFOXIN - Cefoxitin - Class H
-
MIASTINE - Rosuvastatin - Class A - RR - Note 13
Musculoskeletal
-
NAVIZAN - Tizanidine - Class C - RR
-
NEBULGEN - Flunisolide - Class A - RR